- Home
- BLTE vs PACS Comparison
BLTE vs PACS Comparison
Compare BLTE & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- PACS
- Stock Information
- Founded
- BLTE 2018
- PACS 2013
- Country
- BLTE United States
- PACS United States
- Employees
- BLTE N/A
- PACS N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- PACS
- Sector
- BLTE Health Care
- PACS
- Exchange
- BLTE Nasdaq
- PACS Nasdaq
- Market Cap
- BLTE 2.6B
- PACS 2.1B
- IPO Year
- BLTE 2022
- PACS 2024
- Fundamental
- Price
- BLTE $93.82
- PACS $12.60
- Analyst Decision
- BLTE Strong Buy
- PACS Buy
- Analyst Count
- BLTE 4
- PACS 4
- Target Price
- BLTE $96.00
- PACS $26.25
- AVG Volume (30 Days)
- BLTE 69.4K
- PACS 723.9K
- Earning Date
- BLTE 11-11-2025
- PACS 11-07-2025
- Dividend Yield
- BLTE N/A
- PACS N/A
- EPS Growth
- BLTE N/A
- PACS 82.80
- EPS
- BLTE N/A
- PACS 0.68
- Revenue
- BLTE N/A
- PACS $3,558,953,000.00
- Revenue This Year
- BLTE N/A
- PACS $28.62
- Revenue Next Year
- BLTE N/A
- PACS $16.94
- P/E Ratio
- BLTE N/A
- PACS $18.59
- Revenue Growth
- BLTE N/A
- PACS 205.08
- 52 Week Low
- BLTE $49.00
- PACS $7.50
- 52 Week High
- BLTE $93.59
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- BLTE 77.42
- PACS 50.26
- Support Level
- BLTE $88.00
- PACS $12.12
- Resistance Level
- BLTE $91.92
- PACS $13.09
- Average True Range (ATR)
- BLTE 3.16
- PACS 0.57
- MACD
- BLTE 0.90
- PACS -0.09
- Stochastic Oscillator
- BLTE 98.97
- PACS 40.79
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.